127 related articles for article (PubMed ID: 32308603)
1. Is Gonadal Therapy a Promoter of Breast Cancer? Incidence of Breast Cancer in a Cohort of Survivors of Oncological Diseases Treated with Gonadal Steroids.
Dias D; Esteves S; Andrade S; Maciel J; Cavaco D; Simões-Pereira J; Pereira MC
Case Rep Oncol; 2020; 13(1):347-357. PubMed ID: 32308603
[TBL] [Abstract][Full Text] [Related]
2. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Knobf MT
Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia and osteoporosis in women with breast cancer.
Ramaswamy B; Shapiro CL
Semin Oncol; 2003 Dec; 30(6):763-75. PubMed ID: 14663777
[TBL] [Abstract][Full Text] [Related]
4. Low bone mineral density is associated with breast cancer in postmenopausal women: a case-control study.
Ferreira Poloni P; Vespoli HL; Almeida-Filho BS; Bueloni-Dias F; Nahas-Neto J; Nahas EAP
Climacteric; 2017 Oct; 20(5):491-497. PubMed ID: 28569124
[TBL] [Abstract][Full Text] [Related]
5. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
McCune JS; Games DM; Espirito JL
J Oncol Pharm Pract; 2005 Jun; 11(2):37-43. PubMed ID: 16460603
[TBL] [Abstract][Full Text] [Related]
6. Estrogen replacement therapy after breast cancer: a 12-year follow-up.
Peters GN; Fodera T; Sabol J; Jones S; Euhus D
Ann Surg Oncol; 2001 Dec; 8(10):828-32. PubMed ID: 11776498
[TBL] [Abstract][Full Text] [Related]
7. Bone health management of Australian breast cancer survivors receiving hormonal therapy.
Roberts R; Miller M; O'Callaghan M; Koczwara B
Intern Med J; 2015 Nov; 45(11):1182-5. PubMed ID: 26348867
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
9. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
Bromley SE; Matthews A; Smeeth L; Stanway S; Bhaskaran K
J Cancer Surviv; 2019 Aug; 13(4):632-640. PubMed ID: 31321612
[TBL] [Abstract][Full Text] [Related]
10. Exogenous reproductive hormone use in breast cancer survivors and previvors.
Vaz-Luis I; Partridge AH
Nat Rev Clin Oncol; 2018 Apr; 15(4):249-261. PubMed ID: 29358778
[TBL] [Abstract][Full Text] [Related]
11. Skeletal health in breast cancer survivors.
Bruyère O; Bergmann P; Cavalier E; Gielen E; Goemaere S; Kaufman JM; Rozenberg S; Body JJ
Maturitas; 2017 Nov; 105():78-82. PubMed ID: 28838807
[TBL] [Abstract][Full Text] [Related]
12. Incidences of breast cancer throughout long-term hormone replacement therapy.
Cortés-Prieto J; Juez-Martel P
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):180-9. PubMed ID: 17467269
[TBL] [Abstract][Full Text] [Related]
13. Menopause after breast cancer: a survey on breast cancer survivors.
Biglia N; Cozzarella M; Cacciari F; Ponzone R; Roagna R; Maggiorotto F; Sismondi P
Maturitas; 2003 May; 45(1):29-38. PubMed ID: 12753941
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of low bone mineral density in postmenopausal breast cancer survivors].
Poloni PF; Omodei MS; Nahas-Neto J; Uemura G; Véspoli Hde L; Nahas EA
Rev Bras Ginecol Obstet; 2015 Jan; 37(1):30-5. PubMed ID: 25607127
[TBL] [Abstract][Full Text] [Related]
15. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
16. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
17. Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?
Garrido Oyarzún MF; Castelo-Branco C
Gynecol Endocrinol; 2017 Jan; 33(1):10-15. PubMed ID: 27898259
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal survivors of breast cancer at risk for osteoporosis: nutritional intake and body size.
Lindsey AM; Gross G; Twiss J; Waltman N; Ott C; Moore TE
Cancer Nurs; 2002 Feb; 25(1):50-6. PubMed ID: 11838720
[TBL] [Abstract][Full Text] [Related]
19. Ovarian function and childbearing issues in breast cancer survivors.
Gadducci A; Cosio S; Genazzani AR
Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Survival of Women with Breast Cancer. Overview Supportive Care Needs Assessment Instruments.
Ktistaki P; Alevra N; Voulgari M
Adv Exp Med Biol; 2017; 989():281-284. PubMed ID: 28971436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
